NexTier Oilfield Solutions Inc. NEX
10.61 0.00 (+0.00%)
At closeAug 31, 2023, 4:00 PM EDT
10.38 Day range 10.78
52-week range unavailable
- Market cap
- 2.42B
- Volume
- 600
- Open
- 10.62
- Previous close
- 10.61
- Day's range
- 10.38 – 10.78
- Earnings date
- Oct 24, 2023
YTD +2.12 (+24.97%)
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Oct 24, 2023
Expected Oct 24, 2023. Consensus EPS estimate 0.00.
Financials — quick view
NEX Revenue — quarterly 945.09M
NEX Net income — quarterly 150.06M
NEX EPS — quarterly 0.66
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 24, 2023 | Sep 1, 2023 | 0.49 | — | — | — |
| Jul 25, 2023 | Jun 1, 2023 | 0.69 | — | — | — |
| Apr 25, 2023 | Mar 1, 2023 | 0.65 | — | — | — |
| Feb 15, 2023 | Dec 1, 2022 | 0.46 | — | — | — |
| Oct 25, 2022 | Sep 1, 2022 | 0.49 | — | — | — |
| Jul 26, 2022 | Jun 1, 2022 | 0.35 | — | — | — |
News
Appili Therapeutics Announces Transfer to NEX 
Water Ways Announces Appointment of New Director and Notice to Potential Transfer to NEX 
Clean Seed Capital Announces TSX Venture Reactivation 
Bitget lists Nexus (NEX) for Spot Trading 
KGL Resources Announces Trading Symbol Change 
Axonex Intelligence's AI Robotics Series Makes a Splash at InnoEX Featuring NEX's Debut in Hong Kong As AXONEX Showcases Its Latest Robotics Portfolio 
Altai Announces Transfer of Listing to NEX 
Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-T™ CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025 
Shareholders of Patterson-UTI Energy and NexTier Oilfield Solutions Approve Merger of Equals 
Goosehead Insurance and Jackson Financial Set to Join S&P SmallCap 600
Your note
Sign in to keep a note on NEX — it syncs with the Stock Master app.